These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 33119213

  • 1. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
    Ramani NS, Chen H, Broaddus RR, Lazar AJ, Luthra R, Medeiros LJ, Patel KP, Rashid A, Routbort MJ, Stewart J, Tang Z, Bassett R, Manekia J, Barkoh BA, Dang H, Roy-Chowdhuri S.
    Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions.
    Han LM, Khanafshar E, Afshar AR, Calkins SM.
    Cancer Cytopathol; 2020 Jul; 128(7):499-505. PubMed ID: 32196967
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma.
    Baum JE, Zhang P, Hoda RS, Geraghty B, Rennert H, Narula N, Fernandes HD.
    Cancer Cytopathol; 2017 Jun; 125(6):398-406. PubMed ID: 28272845
    [Abstract] [Full Text] [Related]

  • 6. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
    Seto K, Masago K, Fujita S, Haneda M, Horio Y, Hida T, Kuroda H, Hosoda W, Okubo KI.
    Thorac Cancer; 2020 Jul; 11(7):1827-1834. PubMed ID: 32372482
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL, Montgomery ND, Patel NM, Civalier CJ, Dodd LG, Gulley ML, Booker JK, Weck KE.
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [Abstract] [Full Text] [Related]

  • 10. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
    Velizheva NP, Rechsteiner MP, Wong CE, Zhong Q, Rössle M, Bode B, Moch H, Soltermann A, Wild PJ, Tischler V.
    Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
    [Abstract] [Full Text] [Related]

  • 11. Thyroid cytology smear slides: An untapped resource for ThyroSeq testing.
    Nikiforova MN, Lepe M, Tolino LA, Miller ME, Ohori NP, Wald AI, Landau MS, Kaya C, Malapelle U, Bellevicine C, Troncone G, Nikiforov YE, Baloch Z.
    Cancer Cytopathol; 2021 Jan; 129(1):33-42. PubMed ID: 32697051
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preanalytic Variables in Cytology: Lessons Learned From Next-Generation Sequencing-The MD Anderson Experience.
    Roy-Chowdhuri S, Stewart J.
    Arch Pathol Lab Med; 2016 Nov; 140(11):1191-1199. PubMed ID: 27333361
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Stoy SP, Segal JP, Mueller J, Furtado LV, Vokes EE, Patel JD, Murgu S.
    Clin Lung Cancer; 2018 May; 19(3):230-238.e2. PubMed ID: 29277564
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.